Highly Enantioselective Synthesis of Pharmaceuticals at Chiral-Encoded Metal Surfaces.

Invited for the cover of this issue are the groups of Chularat Wattanakit and Alexander Kuhn at the Vidyasirimedhi Institute of Science and Technology and the University of Bordeaux. The two tunnels in the image illustrate the entrance into a porous heterogeneous catalyst for the stereoselective transformation of adrenalone into the desired epinephrine stereoisomer. Read the full text of the article at 10.1002/chem.202302054.

Highly Enantioselective Synthesis of Pharmaceuticals at Chiral-Encoded Metal Surfaces.

Enantioselective catalysis is of crucial importance in modern chemistry and pharmaceutical science. Although various concepts have been used for the development of enantioselective catalysts to obtain highly pure chiral compounds, most of them are based on homogeneous catalytic systems. Recently, we successfully developed nanostructured metal layers imprinted with chiral information, which were applied as electrocatalysts for the enantioselective synthesis of chiral model compounds. However, so far such materials have not been employed as heterogeneous catalysts for the enantioselective synthesis of real pharmaceutical products. In this contribution, we report the asymmetric synthesis of chiral pharmaceuticals (CPs) with chiral imprinted Pt-Ir surfaces as a simple hydrogenation catalyst. By fine-tuning the experimental parameters, a very high enantioselectivity (up to 95 % enantiomeric excess) with good catalyst stability can be achieved. The designed materials were also successfully used as catalytically active stationary phases for the continuous asymmetric flow synthesis of pharmaceutical compounds. This illustrates the possibility of producing real chiral pharmaceuticals at such nanostructured metal surfaces for the first time.